| Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges |
|
International Journal of Laboratory Hematology |
Myelodysplastic Syndromes (MDS) |
| Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes. |
|
Bone Marrow Transplant |
Myelodysplastic Syndromes (MDS) |
| Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia |
|
International Journal of Hematology |
Aplastic Anemia |
| Morphologic Characteristics of Myelodysplastic Syndromes |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Monitoring and treatment of MDS in genetically susceptible persons |
|
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
| Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia |
|
Blood Advances |
Aplastic Anemia |
| Modified Delphi panel consensus recommendations for management of severe aplastic anemia |
|
Blood Advances |
Aplastic Anemia |
